Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 57% ± 29% | |
| astrocyte | 9 studies | 31% ± 15% | |
| oligodendrocyte | 8 studies | 29% ± 13% | |
| interneuron | 6 studies | 37% ± 21% | |
| retinal ganglion cell | 6 studies | 50% ± 15% | |
| GABAergic neuron | 6 studies | 55% ± 20% | |
| neuron | 4 studies | 35% ± 8% | |
| granule cell | 4 studies | 37% ± 13% | |
| GABAergic interneuron | 3 studies | 37% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 15 studies | 37% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 15273.64 | 2641 / 2642 | 84% | 24.78 | 592 / 705 |
| uterus | 85% | 2979.99 | 145 / 170 | 50% | 8.01 | 230 / 459 |
| prostate | 30% | 601.22 | 73 / 245 | 81% | 8.66 | 407 / 502 |
| esophagus | 39% | 2120.53 | 570 / 1445 | 58% | 14.83 | 106 / 183 |
| skin | 76% | 3755.96 | 1372 / 1809 | 10% | 0.93 | 46 / 472 |
| adrenal gland | 4% | 73.40 | 10 / 258 | 81% | 20.70 | 186 / 230 |
| breast | 0% | 4.53 | 1 / 459 | 55% | 9.43 | 618 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 12.19 | 24 / 45 |
| lung | 0% | 0 | 0 / 578 | 47% | 8.56 | 540 / 1155 |
| pancreas | 0% | 0 | 0 / 328 | 40% | 4.85 | 71 / 178 |
| bladder | 5% | 55.57 | 1 / 21 | 23% | 2.89 | 115 / 504 |
| intestine | 0% | 1.45 | 1 / 966 | 23% | 2.01 | 121 / 527 |
| ovary | 2% | 29.81 | 3 / 180 | 17% | 1.53 | 73 / 430 |
| liver | 0% | 0 | 0 / 226 | 18% | 1.98 | 75 / 406 |
| stomach | 1% | 6.37 | 2 / 359 | 15% | 1.44 | 44 / 286 |
| kidney | 0% | 0 | 0 / 89 | 11% | 1.18 | 95 / 901 |
| thymus | 0% | 0 | 0 / 653 | 7% | 0.92 | 40 / 605 |
| blood vessel | 3% | 86.13 | 40 / 1335 | 0% | 0 | 0 / 0 |
| heart | 2% | 26.10 | 15 / 861 | 0% | 0 | 0 / 0 |
| adipose | 2% | 36.70 | 20 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.13 | 1 / 80 |
| muscle | 0% | 1.55 | 1 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 3.26 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005829 | Cellular component | cytosol |
| GO_0000159 | Cellular component | protein phosphatase type 2A complex |
| GO_0019888 | Molecular function | protein phosphatase regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPP2R2C |
| Protein name | Alternative protein PPP2R2C Protein phosphatase 2 regulatory subunit Bgamma Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (IMYPNO1) (PP2A subunit B isoform B55-gamma) (PP2A subunit B isoform PR55-gamma) (PP2A subunit B isoform R2-gamma) (PP2A subunit B isoform gamma) |
| Synonyms | |
| Description | FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. |
| Accessions | L8ECI7 ENST00000382599.9 [Q9Y2T4-1] ENST00000515571.5 [Q9Y2T4-3] Q9Y2T4 D6R943 ENST00000509917.1 ENST00000335585.9 [Q9Y2T4-2] ENST00000506140.5 [Q9Y2T4-4] ENST00000507294.1 [Q9Y2T4-4] |
